Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorElana Rosenthal
About this trial
This is a two-group randomized controlled trial conducted at five hospitals across the U.S. designed to test the effectiveness of an Integrated infectious diseases/Substance Use Disorder outpatient clinic (IC) compared to treatment as usual aimed at reducing infection related readmissions and improving health outcomes in people hospitalized with an infection related to injecting opioids or stimulants.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Admitted to study hospital (defined as hospitalized with a primary team that is not Emergency Medicine)
Injection opioid or stimulant use in past 90 days - per patient self-report
Active suspected or confirmed qualifying infection (see list) at time of admission.
Disqualifiers
1. Infection due to a cause other than injection drug use, per determination of a site PI.
Trial design
Treatments tested in this trial
- Integrated Infectious Diseases and Substance Use Disorder Clinic (IC)
Treatment groups
304 Participants
are divided into 2 treatment groupsSponsors and collaborators
Elana Rosenthal
Lead sponsor
University of Maryland, Baltimore
Sponsor institution
Emory University
Collaborator
George Washington University
Collaborator
West Virginia University
Collaborator
Weill Medical College of Cornell University
Collaborator
Friends Research Institute, Inc.
Collaborator
Source ClinicalTrials.gov